Skip to main content

BioLife Sciences (BLFE) Announces Distribution Agreement With BeMotion Inc.

Written by Customer Service on . Posted in Public Companies.

Toronto, Sept. 21, 2020 (GLOBE NEWSWIRE) — via NewMediaWire —BioLife Sciences Inc. (OTC Markets: BLFE) announced today that it has entered into an agreement with BeMotion Inc. to become a licensed distributor of the company’s innovative technology products.
Under the terms of the agreement, BioLife Sciences will gain the right to distribute products by BeMotion which include non-contact human temperature screening technology, ultraviolet sterilization, and touchless vending/marketplaces, currently used by police departments, airports and educational institutions. BeMotion Inc. CEO Mr. Hussein Abu Hassan commented: “We saw a partnership with BioLife Sciences as an excellent opportunity to expand our North American network of sales and distribution.”According to Markets and Markets the global temperature sensor market size is projected to grow from USD 6.3 billion in 2020 to USD 8.8 billion by 2027.  The temperature sensor industry growth is driven mainly by increasing penetration of temperature sensors in advanced and portable healthcare equipment and rising adoption of home and building automation systems.Mr. De Four, CEO of BioLife Sciences, stated: “Partnering with BeMotion enhances our ability to provide safe and reliable solutions to consumers who are looking to keep their families and workforces safe in the post-pandemic world.”  BioLife Sciences’ core building block strategies are to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.BioLife continues to expand its line of products and remain equipped to navigate the existing health crisis. As cases globally increase, industry and government are continuing to mitigate the impact on economic activities, to keep business open and the normalization of the consumer ecosystem. About BioLife Sciences Inc.BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products, non-contact human temperature screening technology, and touchless vending/marketplaces. www.biolifesciences.com                  ir@biolifesciences.comUS +1 775 9810270CA +1 647 5586663 About BeMotion Inc.BeMotion Inc. provides a complete technological & strategic solutions which tap into the next generation of digital opportunities. Established in 2016, BeMotion Inc. has developed and launched mobile digital marketing and payment platforms along with state-of-the-art thermal scanners. BeMotion Inc. is a privately owned company with offices in Toronto, Dubai and London. www.bemotioninc.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.